ID   AGRF5_HUMAN             Reviewed;        1346 AA.
AC   Q8IZF2; O94858; Q5TF06; Q6RGN2; Q86SP0; Q9Y3Z2;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 3.
DT   28-JUN-2023, entry version 181.
DE   RecName: Full=Adhesion G protein-coupled receptor F5 {ECO:0000303|PubMed:25713288};
DE   AltName: Full=G-protein coupled receptor 116;
DE   Flags: Precursor;
GN   Name=ADGRF5 {ECO:0000312|HGNC:HGNC:19030}; Synonyms=GPR116, KIAA0758;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=12435584; DOI=10.1016/s0014-5793(02)03574-3;
RA   Fredriksson R., Lagerstroem M.C., Hoeglund P.J., Schioeth H.B.;
RT   "Novel human G protein-coupled receptors with long N-terminals containing
RT   GPS domains and Ser/Thr-rich regions.";
RL   FEBS Lett. 531:407-414(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-604.
RC   TISSUE=Brain;
RA   Bonner T.I., Nagle J.W., Kauffman D.;
RT   "Complete coding sequence of GPR116.";
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS MET-604
RP   AND THR-856.
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [4]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R., Ishikawa K., Suyama M.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-613 (ISOFORM 1), AND VARIANTS MET-604 AND ILE-801.
RC   TISSUE=Brain, and Cervix;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS MET-604
RP   AND THR-856.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 949-1062.
RX   PubMed=12679517; DOI=10.1073/pnas.0230374100;
RA   Vassilatis D.K., Hohmann J.G., Zeng H., Li F., Ranchalis J.E.,
RA   Mortrud M.T., Brown A., Rodriguez S.S., Weller J.R., Wright A.C.,
RA   Bergmann J.E., Gaitanaris G.A.;
RT   "The G protein-coupled receptor repertoires of human and mouse.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:4903-4908(2003).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-256 AND ASN-315.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [10]
RP   NOMENCLATURE.
RX   PubMed=25713288; DOI=10.1124/pr.114.009647;
RA   Hamann J., Aust G., Arac D., Engel F.B., Formstone C., Fredriksson R.,
RA   Hall R.A., Harty B.L., Kirchhoff C., Knapp B., Krishnan A., Liebscher I.,
RA   Lin H.H., Martinelli D.C., Monk K.R., Peeters M.C., Piao X., Promel S.,
RA   Schoneberg T., Schwartz T.W., Singer K., Stacey M., Ushkaryov Y.A.,
RA   Vallon M., Wolfrum U., Wright M.W., Xu L., Langenhan T., Schioth H.B.;
RT   "International union of basic and clinical pharmacology. XCIV. Adhesion G
RT   protein-coupled receptors.";
RL   Pharmacol. Rev. 67:338-367(2015).
CC   -!- FUNCTION: Receptor that plays a critical role in lung surfactant
CC       homeostasis. May play a role in controlling adipocyte function.
CC       {ECO:0000250|UniProtKB:G5E8Q8}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Heterodimer of 2 chains generated
CC       by proteolytic processing; the large extracellular N-terminal fragment
CC       and the membrane-bound C-terminal fragment predominantly remain
CC       associated and non-covalently linked. Fragment generates by the
CC       processing enzyme furin remains attached to the extracellular N-
CC       terminal fragment. Interacts (via N-terminal extracellular domain) with
CC       SFTPD. {ECO:0000250|UniProtKB:G5E8Q8, ECO:0000250|UniProtKB:Q9WVT0}.
CC   -!- INTERACTION:
CC       Q8IZF2; Q9NPB3: CABP2; NbExp=3; IntAct=EBI-7600130, EBI-12011224;
CC       Q8IZF2; Q53EP0-3: FNDC3B; NbExp=3; IntAct=EBI-7600130, EBI-10242151;
CC       Q8IZF2; Q13952-2: NFYC; NbExp=3; IntAct=EBI-7600130, EBI-11956831;
CC       Q8IZF2; P55735-3: SEC13; NbExp=3; IntAct=EBI-7600130, EBI-12235008;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9WVT0};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IZF2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IZF2-2; Sequence=VSP_010837, VSP_010838;
CC       Name=3;
CC         IsoId=Q8IZF2-3; Sequence=VSP_039130;
CC   -!- PTM: Proteolytically cleaved at multiple sites: one in the GPS domain
CC       (S1 site) and the other in the SEA domain (S2 site). The proteolytic
CC       cleavage at S1 site generates an extracellular subunit and a seven-
CC       transmembrane subunit. The proteolytic cleavage at S2 site generates a
CC       fragment that undergoes proteolytic cleavage by the processing enzyme
CC       furin. {ECO:0000250|UniProtKB:Q9WVT0}.
CC   -!- PTM: Highly glycosylated. {ECO:0000250|UniProtKB:Q9WVT0}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 2 family.
CC       Adhesion G-protein coupled receptor (ADGR) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA34478.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAB43394.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY140958; AAN46672.1; -; mRNA.
DR   EMBL; AY498875; AAS21061.1; -; mRNA.
DR   EMBL; AB018301; BAA34478.2; ALT_INIT; mRNA.
DR   EMBL; AL050295; CAB43394.1; ALT_SEQ; mRNA.
DR   EMBL; AL832125; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL096772; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC066121; AAH66121.1; -; mRNA.
DR   EMBL; AY255552; AAO85064.1; -; mRNA.
DR   CCDS; CCDS4919.1; -. [Q8IZF2-1]
DR   PIR; T08685; T08685.
DR   RefSeq; NP_001091988.1; NM_001098518.1. [Q8IZF2-1]
DR   RefSeq; NP_056049.4; NM_015234.4. [Q8IZF2-1]
DR   AlphaFoldDB; Q8IZF2; -.
DR   SMR; Q8IZF2; -.
DR   BioGRID; 128719; 6.
DR   IntAct; Q8IZF2; 7.
DR   MINT; Q8IZF2; -.
DR   STRING; 9606.ENSP00000283296; -.
DR   ChEMBL; CHEMBL4523888; -.
DR   MEROPS; P02.019; -.
DR   GlyConnect; 1914; 28 N-Linked glycans (14 sites).
DR   GlyCosmos; Q8IZF2; 27 sites, 34 glycans.
DR   GlyGen; Q8IZF2; 28 sites, 29 N-linked glycans (14 sites), 6 O-linked glycans (2 sites).
DR   iPTMnet; Q8IZF2; -.
DR   PhosphoSitePlus; Q8IZF2; -.
DR   BioMuta; ADGRF5; -.
DR   DMDM; 229462973; -.
DR   jPOST; Q8IZF2; -.
DR   MassIVE; Q8IZF2; -.
DR   PaxDb; Q8IZF2; -.
DR   PeptideAtlas; Q8IZF2; -.
DR   ProteomicsDB; 71338; -. [Q8IZF2-1]
DR   ProteomicsDB; 71339; -. [Q8IZF2-2]
DR   ProteomicsDB; 71340; -. [Q8IZF2-3]
DR   Antibodypedia; 16896; 259 antibodies from 28 providers.
DR   DNASU; 221395; -.
DR   Ensembl; ENST00000265417.7; ENSP00000265417.6; ENSG00000069122.19. [Q8IZF2-1]
DR   Ensembl; ENST00000283296.12; ENSP00000283296.7; ENSG00000069122.19. [Q8IZF2-1]
DR   GeneID; 221395; -.
DR   KEGG; hsa:221395; -.
DR   MANE-Select; ENST00000283296.12; ENSP00000283296.7; NM_001098518.2; NP_001091988.1.
DR   UCSC; uc003oyo.5; human. [Q8IZF2-1]
DR   AGR; HGNC:19030; -.
DR   CTD; 221395; -.
DR   DisGeNET; 221395; -.
DR   GeneCards; ADGRF5; -.
DR   HGNC; HGNC:19030; ADGRF5.
DR   HPA; ENSG00000069122; Tissue enhanced (lung).
DR   neXtProt; NX_Q8IZF2; -.
DR   OpenTargets; ENSG00000069122; -.
DR   PharmGKB; PA134886165; -.
DR   VEuPathDB; HostDB:ENSG00000069122; -.
DR   eggNOG; KOG4193; Eukaryota.
DR   GeneTree; ENSGT00940000154603; -.
DR   HOGENOM; CLU_002753_3_5_1; -.
DR   InParanoid; Q8IZF2; -.
DR   OMA; VADTWFI; -.
DR   OrthoDB; 3876300at2759; -.
DR   PhylomeDB; Q8IZF2; -.
DR   TreeFam; TF316380; -.
DR   PathwayCommons; Q8IZF2; -.
DR   Reactome; R-HSA-5683826; Surfactant metabolism.
DR   SignaLink; Q8IZF2; -.
DR   BioGRID-ORCS; 221395; 16 hits in 1149 CRISPR screens.
DR   ChiTaRS; ADGRF5; human.
DR   GeneWiki; GPR116; -.
DR   GenomeRNAi; 221395; -.
DR   Pharos; Q8IZF2; Tbio.
DR   PRO; PR:Q8IZF2; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q8IZF2; protein.
DR   Bgee; ENSG00000069122; Expressed in lower lobe of lung and 194 other tissues.
DR   Genevisible; Q8IZF2; HS.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:MGI.
DR   GO; GO:0016020; C:membrane; TAS:GDB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0006112; P:energy reserve metabolic process; IBA:GO_Central.
DR   GO; GO:0048821; P:erythrocyte development; IEA:Ensembl.
DR   GO; GO:0045444; P:fat cell differentiation; IBA:GO_Central.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:GDB.
DR   GO; GO:0003094; P:glomerular filtration; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0042116; P:macrophage activation; IEA:Ensembl.
DR   GO; GO:0043031; P:negative regulation of macrophage activation; IEA:Ensembl.
DR   GO; GO:0061626; P:pharyngeal arch artery morphogenesis; IEA:Ensembl.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0071073; P:positive regulation of phospholipid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; IBA:GO_Central.
DR   GO; GO:0043129; P:surfactant homeostasis; IEA:Ensembl.
DR   CDD; cd15254; 7tmB2_GPR116_Ig-Hepta; 1.
DR   Gene3D; 2.60.220.50; -; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   Gene3D; 3.30.70.960; SEA domain; 1.
DR   InterPro; IPR046338; GAIN_dom_sf.
DR   InterPro; IPR017981; GPCR_2-like_TM.
DR   InterPro; IPR008078; GPCR_2_Ig-hepta-like_rcpt.
DR   InterPro; IPR000832; GPCR_2_secretin-like.
DR   InterPro; IPR017983; GPCR_2_secretin-like_CS.
DR   InterPro; IPR000203; GPS.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   PANTHER; PTHR45813; -; 1.
DR   PANTHER; PTHR45813:SF4; ADHESION G PROTEIN-COUPLED RECEPTOR F5; 1.
DR   Pfam; PF00002; 7tm_2; 1.
DR   Pfam; PF01825; GPS; 1.
DR   Pfam; PF13927; Ig_3; 1.
DR   Pfam; PF01390; SEA; 1.
DR   PRINTS; PR00249; GPCRSECRETIN.
DR   PRINTS; PR01695; IGHEPTARCPTR.
DR   SMART; SM00303; GPS; 1.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 2.
DR   SUPFAM; SSF82671; SEA domain; 1.
DR   PROSITE; PS00650; G_PROTEIN_RECEP_F2_2; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
DR   PROSITE; PS50221; GPS; 1.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS50024; SEA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Immunoglobulin domain; Membrane;
KW   Phosphoprotein; Receptor; Reference proteome; Repeat; Signal; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..1346
FT                   /note="Adhesion G protein-coupled receptor F5"
FT                   /id="PRO_0000012896"
FT   TOPO_DOM        22..1006
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1007..1027
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1028..1053
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1054..1074
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1075..1090
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1091..1111
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1112..1128
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1129..1149
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1150..1173
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1174..1194
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1195..1220
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1221..1241
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1242..1244
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1245..1265
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1266..1346
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          166..273
FT                   /note="SEA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   DOMAIN          267..368
FT                   /note="Ig-like 1"
FT   DOMAIN          369..466
FT                   /note="Ig-like 2"
FT   DOMAIN          471..561
FT                   /note="Ig-like 3"
FT   DOMAIN          951..1002
FT                   /note="GPS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
FT   REGION          1327..1346
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            51..52
FT                   /note="Cleavage; by furin"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVT0"
FT   SITE            226..227
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVT0"
FT   SITE            990..991
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVT0"
FT   MOD_RES         1300
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:G5E8Q8"
FT   MOD_RES         1307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:G5E8Q8"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        94
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        106
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        188
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        256
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        272
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        301
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        315
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        328
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        398
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        472
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        487
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        505
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        540
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        627
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        649
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        666
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        820
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        931
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        963
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        982
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        293..350
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        391..449
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        492..545
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         272..414
FT                   /note="NESNFFVTPEIIFEGDTVSLVCEKEVLSSNVSWRYEEQQLEIQNSSRFSIYT
FT                   ALFNNMTSVSKLTIHNITPGDAGEYVCKLILDIFEYECKKKIDVMPIQILANEEMKVMC
FT                   DNNPVSLNCCSQGNVNWSKVEWKQEGKINIPG -> R (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_039130"
FT   VAR_SEQ         1273..1292
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12435584"
FT                   /id="VSP_010837"
FT   VAR_SEQ         1322..1346
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12435584"
FT                   /id="VSP_010838"
FT   VARIANT         604
FT                   /note="T -> M (in dbSNP:rs586024)"
FT                   /evidence="ECO:0000269|PubMed:10048485,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005,
FT                   ECO:0000269|Ref.2"
FT                   /id="VAR_025326"
FT   VARIANT         801
FT                   /note="V -> I (in dbSNP:rs9395218)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_055291"
FT   VARIANT         856
FT                   /note="M -> T (in dbSNP:rs547499)"
FT                   /evidence="ECO:0000269|PubMed:10048485,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_024477"
FT   CONFLICT        272
FT                   /note="Missing (in Ref. 1; AAN46672)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        573
FT                   /note="V -> I (in Ref. 7; CAB43394)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1075
FT                   /note="Q -> R (in Ref. 5; AL832125)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1346 AA;  149457 MW;  72A9D02B08218A60 CRC64;
     MKSPRRTTLC LMFIVIYSSK AALNWNYEST IHPLSLHEHE PAGEEALRQK RAVATKSPTA
     EEYTVNIEIS FENASFLDPI KAYLNSLSFP IHGNNTDQIT DILSINVTTV CRPAGNEIWC
     SCETGYGWPR ERCLHNLICQ ERDVFLPGHH CSCLKELPPN GPFCLLQEDV TLNMRVRLNV
     GFQEDLMNTS SALYRSYKTD LETAFRKGYG ILPGFKGVTV TGFKSGSVVV TYEVKTTPPS
     LELIHKANEQ VVQSLNQTYK MDYNSFQAVT INESNFFVTP EIIFEGDTVS LVCEKEVLSS
     NVSWRYEEQQ LEIQNSSRFS IYTALFNNMT SVSKLTIHNI TPGDAGEYVC KLILDIFEYE
     CKKKIDVMPI QILANEEMKV MCDNNPVSLN CCSQGNVNWS KVEWKQEGKI NIPGTPETDI
     DSSCSRYTLK ADGTQCPSGS SGTTVIYTCE FISAYGARGS ANIKVTFISV ANLTITPDPI
     SVSEGQNFSI KCISDVSNYD EVYWNTSAGI KIYQRFYTTR RYLDGAESVL TVKTSTREWN
     GTYHCIFRYK NSYSIATKDV IVHPLPLKLN IMVDPLEATV SCSGSHHIKC CIEEDGDYKV
     TFHTGSSSLP AAKEVNKKQV CYKHNFNASS VSWCSKTVDV CCHFTNAANN SVWSPSMKLN
     LVPGENITCQ DPVIGVGEPG KVIQKLCRFS NVPSSPESPI GGTITYKCVG SQWEEKRNDC
     ISAPINSLLQ MAKALIKSPS QDEMLPTYLK DLSISIDKAE HEISSSPGSL GAIINILDLL
     STVPTQVNSE MMTHVLSTVN VILGKPVLNT WKVLQQQWTN QSSQLLHSVE RFSQALQSGD
     SPPLSFSQTN VQMSSMVIKS SHPETYQQRF VFPYFDLWGN VVIDKSYLEN LQSDSSIVTM
     AFPTLQAILA QDIQENNFAE SLVMTTTVSH NTTMPFRISM TFKNNSPSGG ETKCVFWNFR
     LANNTGGWDS SGCYVEEGDG DNVTCICDHL TSFSILMSPD SPDPSSLLGI LLDIISYVGV
     GFSILSLAAC LVVEAVVWKS VTKNRTSYMR HTCIVNIAAS LLVANTWFIV VAAIQDNRYI
     LCKTACVAAT FFIHFFYLSV FFWMLTLGLM LFYRLVFILH ETSRSTQKAI AFCLGYGCPL
     AISVITLGAT QPREVYTRKN VCWLNWEDTK ALLAFAIPAL IIVVVNITIT IVVITKILRP
     SIGDKPCKQE KSSLFQISKS IGVLTPLLGL TWGFGLTTVF PGTNLVFHII FAILNVFQGL
     FILLFGCLWD LKVQEALLNK FSLSRWSSQH SKSTSLGSST PVFSMSSPIS RRFNNLFGKT
     GTYNVSTPEA TSSSLENSSS ASSLLN
//
